Loading...
Header Logo
Keywords
Last Name
Institution

TONY EISSA

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Pulmonary
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular & Cellular Biology
    DivisionMolecular & Cellular Biology

    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular Physiology & Biophysics
    DivisionMolecular Physiology & Biophysics

    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Pathology & Immunology
    DivisionImmunology


    Collapse ORNG Applications 
    Collapse Faculty Mentor
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    T32HL007747     (EISSA, N. TONY)Jul 1, 1993 - Jun 30, 2021
    NIH/NHLBI
    Research Training in Lung Disease
    Role: Principal Investigator

    R01HL069033     (EISSA, TONY)Dec 1, 2001 - Apr 30, 2014
    NIH/NHLBI
    Molecular Mechanisms of iNOS Degradation
    Role: Principal Investigator

    K02AI055596     (EISSA, TONY)Jul 1, 2003 - Oct 30, 2008
    NIH/NIAID
    Molecular Mechanisms of iNOS Degradation
    Role: Principal Investigator

    R01HL075421     (EISSA, TONY)Dec 15, 2003 - Nov 30, 2010
    NIH/NHLBI
    Posttranslational Molecular Regulation of Human iNOS
    Role: Principal Investigator

    R01HL080205     (EISSA, TONY)May 1, 2006 - Feb 28, 2013
    NIH/NHLBI
    iNOS Aggresome as a Prototype of a Physiologic Aggresome
    Role: Principal Investigator

    U19AI070973     (EISSA, TONY)Jul 15, 2006 - Jun 30, 2012
    NIH/NIAID
    Innate Immunity in Allergic Airway Inflammation of Asthma
    Role: Principal Investigator

    R01HL084322     (EISSA, TONY)Feb 1, 2007 - Jan 31, 2013
    NIH/NHLBI
    Cellular Regulation of Nitric Oxide in Airway Inflammation
    Role: Principal Investigator

    UH2TR000961     (EISSA, TONY)Jun 18, 2013 - May 31, 2014
    NIH/NCATS
    Therapeutic Strategy for LAM (Lymphangioleiomyomatosis)
    Role: Principal Investigator

    UH3TR000961     (EISSA, N TONY)Jun 18, 2013 - Aug 31, 2017
    NIH/NCATS
    Therapeutic Strategy for LAM (Lymphangioleiomyomatosis)
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Estrella JL, Kan-Sutton C, Gong X, Rajagopalan M, Lewis DE, Hunter RL, Eissa NT, Jagannath C. A Novel in vitro Human Macrophage Model to Study the Persistence of Mycobacterium tuberculosis Using Vitamin D(3) and Retinoic Acid Activated THP-1 Macrophages. Front Microbiol. 2011; 2:67. PMID: 21747789.
      View in: PubMed
    2. Jung SY, Li Y, Wang Y, Chen Y, Zhao Y, Qin J. Complications in the assignment of 14 and 28 Da mass shift detected by mass spectrometry as in vivo methylation from endogenous proteins. Anal Chem. 2008 Mar 01; 80(5):1721-9. PMID: 18247584.
      View in: PubMed
    3. Xu Y, Liu XD, Gong X, Eissa NT. Signaling pathway of autophagy associated with innate immunity. Autophagy. 2008 Jan; 4(1):110-2. PMID: 18059159.
      View in: PubMed
    4. Xu Y, Jagannath C, Liu XD, Sharafkhaneh A, Kolodziejska KE, Eissa NT. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity. 2007 Jul; 27(1):135-44. PMID: 17658277.
      View in: PubMed
    5. Lee SH, Nishino M, Mazumdar T, Garcia GE, Galfione M, Lee FL, Lee CL, Liang A, Kim J, Feng L, Eissa NT, Lin SH, Yu-Lee LY. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway. Cancer Res. 2005 Sep 01; 65(17):7984-92. PMID: 16140971.
      View in: PubMed
    6. Kolodziejska KE, Burns AR, Moore RH, Stenoien DL, Eissa NT. Regulation of inducible nitric oxide synthase by aggresome formation. Proc Natl Acad Sci U S A. 2005 Mar 29; 102(13):4854-9. PMID: 15781872.
      View in: PubMed
    7. Mazumdar T, Eissa NT. Preferential recognition of undisruptable dimers of inducible nitric oxide synthase by a monoclonal antibody directed against an N-terminal epitope. J Immunol. 2005 Feb 15; 174(4):2314-7. PMID: 15699167.
      View in: PubMed
    8. Kolodziejski PJ, Musial A, Koo JS, Eissa NT. Ubiquitination of inducible nitric oxide synthase is required for its degradation. Proc Natl Acad Sci U S A. 2002 Sep 17; 99(19):12315-20. PMID: 12221289.
      View in: PubMed
    9. Eissa NT, Haggerty CM, Palmer CD, Patton W, Moss J. Identification of residues critical for enzymatic activity in the domain encoded by exons 8 and 9 of the human inducible nitric oxide synthase. Am J Respir Cell Mol Biol. 2001 May; 24(5):616-20. PMID: 11350832.
      View in: PubMed
    10. Musial A, Eissa NT. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. J Biol Chem. 2001 Jun 29; 276(26):24268-73. PMID: 11312270.
      View in: PubMed
    11. Guo FH, Comhair SA, Zheng S, Dweik RA, Eissa NT, Thomassen MJ, Calhoun W, Erzurum SC. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol. 2000 Jun 01; 164(11):5970-80. PMID: 10820280.
      View in: PubMed
    12. Novoradovsky A, Brantly ML, Waclawiw MA, Chaudhary PP, Ihara H, Qi L, Eissa NT, Barnes PM, Gabriele KM, Ehrmantraut ME, Rogliani P, Moss J. Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol. 1999 Mar; 20(3):441-7. PMID: 10030842.
      View in: PubMed
    13. Wersto RP, Rosenthal ER, Seth PK, Eissa NT, Donahue RE. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. J Virol. 1998 Dec; 72(12):9491-502. PMID: 9811682.
      View in: PubMed
    14. Eissa NT. Nitric oxide in acute lung injury. Intensive Care Med. 1998 Nov; 24(11):1226-7. PMID: 9876988.
      View in: PubMed
    15. Danel C, Erzurum SC, Prayssac P, Eissa NT, Crystal RG, Hervé P, Baudet B, Mazmanian M, Lemarchand P. Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. Hum Gene Ther. 1998 Jul 01; 9(10):1487-96. PMID: 9681420.
      View in: PubMed
    16. Eissa NT, Yuan JW, Haggerty CM, Choo EK, Palmer CD, Moss J. Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization. Proc Natl Acad Sci U S A. 1998 Jun 23; 95(13):7625-30. PMID: 9636200.
      View in: PubMed
    17. Eissa NT, Strauss AJ, Haggerty CM, Choo EK, Chu SC, Moss J. Alternative splicing of human inducible nitric-oxide synthase mRNA. tissue-specific regulation and induction by cytokines. J Biol Chem. 1996 Oct 25; 271(43):27184-7. PMID: 8900212.
      View in: PubMed
    18. Korst RJ, McElvaney NG, Chu CS, Rosenfeld MA, Mastrangeli A, Hay J, Brody SL, Eissa NT, Danel C, Jaffe HA, et al. Gene therapy for the respiratory manifestations of cystic fibrosis. Am J Respir Crit Care Med. 1995 Mar; 151(3 Pt 2):S75-87. PMID: 7533609.
      View in: PubMed
    19. Crystal RG, McElvaney NG, Rosenfeld MA, Chu CS, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eissa NT, Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet. 1994 Sep; 8(1):42-51. PMID: 7527271.
      View in: PubMed
    20. Eissa NT, Chu CS, Danel C, Crystal RG. Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a- adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis. Hum Gene Ther. 1994 Sep; 5(9):1105-14. PMID: 7833370.
      View in: PubMed
    21. Coussa ML, Guérin C, Eissa NT, Corbeil C, Chassé M, Braidy J, Matar N, Milic-Emili J. Partitioning of work of breathing in mechanically ventilated COPD patients. J Appl Physiol (1985). 1993 Oct; 75(4):1711-9. PMID: 8282624.
      View in: PubMed
    22. Guérin C, Coussa ML, Eissa NT, Corbeil C, Chassé M, Braidy J, Matar N, Milic-Emili J. Lung and chest wall mechanics in mechanically ventilated COPD patients. J Appl Physiol (1985). 1993 Apr; 74(4):1570-80. PMID: 8514671.
      View in: PubMed
    23. Valta P, Takala J, Eissa NT, Milic-Emili J. Does alveolar recruitment occur with positive end-expiratory pressure in adult respiratory distress syndrome patients? J Crit Care. 1993 Mar; 8(1):34-42. PMID: 8343857.
      View in: PubMed
    24. Kiiski R, Takala J, Eissa NT. Measurement of alveolar ventilation and changes in deadspace by indirect calorimetry during mechanical ventilation: a laboratory and clinical validation. Crit Care Med. 1991 Oct; 19(10):1303-9. PMID: 1914488.
      View in: PubMed
    25. Eissa NT, Ranieri VM, Corbeil C, Chassé M, Robatto FM, Braidy J, Milic-Emili J. Analysis of behavior of the respiratory system in ARDS patients: effects of flow, volume, and time. J Appl Physiol (1985). 1991 Jun; 70(6):2719-29. PMID: 1885468.
      View in: PubMed
    26. Pesola GR, Hogg JE, Eissa N, Matthews DE, Carlon GC. Hypertonic nasogastric tube feedings: do they cause diarrhea? Crit Care Med. 1990 Dec; 18(12):1378-82. PMID: 2123143.
      View in: PubMed
    27. Eissa NT, Kvetan V. Guide wire as a cause of complete heart block in patients with preexisting left bundle branch block. Anesthesiology. 1990 Oct; 73(4):772-4. PMID: 2221445.
      View in: PubMed
    EISSA's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description